Connection
Linda Watkins to Follow-Up Studies
This is a "connection" page, showing publications Linda Watkins has written about Follow-Up Studies.
|
|
Connection Strength |
|
 |
|
 |
|
0.010 |
|
|
|
-
Ledeboer A, Hutchinson MR, Watkins LR, Johnson KW. Ibudilast (AV-411). A new class therapeutic candidate for neuropathic pain and opioid withdrawal syndromes. Expert Opin Investig Drugs. 2007 Jul; 16(7):935-50.
Score: 0.010